Cargando…

Comparative study of novel dosing schedules for interrupted immunotherapy for allergic rhinitis

Detalles Bibliográficos
Autores principales:	Xi, Lin, Wang, Chengshuo, Gao, Yunbo, Zhang, Yuan, Zhang, Luo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012097/ https://www.ncbi.nlm.nih.gov/pubmed/35441004 http://dx.doi.org/10.1002/clt2.12147

Ejemplares similares

Clinical response to subcutaneous immunotherapy at 3 years in allergic rhinitis patients is predicted by short‐term treatment effectiveness
por: Liu, Dong, et al.
Publicado: (2023)

Long-term efficacy of HDM-SCIT in pediatric and adult patients with allergic rhinitis
por: Ren, Lei, et al.
Publicado: (2023)

Omalizumab is effective in the preseasonal treatment of seasonal allergic rhinitis
por: Zhang, Yuan, et al.
Publicado: (2022)

Association between component-resolved diagnosis of house dust mite and efficacy of allergen immunotherapy in allergic rhinitis patients
por: Huang, Yanran, et al.
Publicado: (2019)

Direct and indirect costs of allergic and non‐allergic rhinitis to adults in Beijing, China
por: Li, Xian, et al.
Publicado: (2022)

Developing nomograms for identifying allergic rhinitis among chronic rhinitis: A real-world study
por: Huang, Yanran, et al.
Publicado: (2021)

Comparison of Long-term Efficacy of Subcutaneous Immunotherapy in Pediatric and Adult Patients With Allergic Rhinitis
por: Huang, Yanran, et al.
Publicado: (2018)

Artemisia Annua sublingual immunotherapy for seasonal allergic rhinitis: A multicenter, randomized trial
por: Lou, Hongfei, et al.
Publicado: (2020)

Replication study of susceptibility variants associated with allergic rhinitis and allergy in Han Chinese
por: Gao, Yunbo, et al.
Publicado: (2020)

Efficacy and immunological changes of sublingual immunotherapy in pediatric allergic rhinitis
por: Zeng, Yinhui, et al.
Publicado: (2023)

Allergic rhinitis: the eligible candidate to mite immunotherapy in the real world
por: Ciprandi, Giorgio, et al.
Publicado: (2017)

Sublingual immunotherapy in allergic rhinitis
por: Han, Doo Hee, et al.
Publicado: (2011)

Chinese Guideline on Allergen Immunotherapy for Allergic Rhinitis: The 2022 Update
por: Wang, Chengshuo, et al.
Publicado: (2022)

Naso-ocular neuropeptide interactions in allergic rhinoconjunctivitis, rhinitis, and conjunctivitis
por: Meng, Yifan, et al.
Publicado: (2021)

Management Practice of Allergic Rhinitis in China During the COVID-19 Pandemic
por: Zhang, Yuan, et al.
Publicado: (2020)

Recent Updates of Immunotherapy for Allergic Rhinitis in Children
por: Lin, Chih-Feng, et al.
Publicado: (2023)

Mechanisms of Allergen Immunotherapy in Allergic Rhinitis
por: Drazdauskaitė, Gabija, et al.
Publicado: (2020)

Immunotherapy in the Treatment of Allergic Rhinitis in Children
por: Alamri, Ruba A, et al.
Publicado: (2022)

Prevalence of Allergic Rhinitis in China
por: Zhang, Yuan, et al.
Publicado: (2014)

Identification of rare variants of allergic rhinitis based on whole genome sequencing and gene expression profiling: A preliminary investigation in four families
por: Zhang, Yuan, et al.
Publicado: (2019)

Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen
por: Gotoh, Minoru, et al.
Publicado: (2022)

Local Nasal Specific Immunotherapy for Allergic Rhinitis
por: Passalacqua, Giovanni, et al.
Publicado: (2006)

Specific immunotherapy (SIT) in the treatment of allergic rhinitis
por: Hagen, Anja, et al.
Publicado: (2010)

Allergen immunotherapy and allergic rhinitis: false beliefs
por: Calderón, Moisés A, et al.
Publicado: (2013)

Subcutaneous Immunotherapy Improves the Symptomatology of Allergic Rhinitis
por: Lourenço, Edmir Américo, et al.
Publicado: (2015)

Preference for Immunotherapy with Tablets by People with Allergic Rhinitis
por: Tankersley, Mike, et al.
Publicado: (2021)

Mechanism and clinical evidence of immunotherapy in allergic rhinitis
por: De Carli, Marco, et al.
Publicado: (2023)

Increasing Prevalence of Allergic Rhinitis in China
por: Zhang, Yuan, et al.
Publicado: (2018)

Suppression of Immunotherapy on Group 2 Innate Lymphoid Cells in Allergic Rhinitis
por: Fan, Da-Chuan, et al.
Publicado: (2016)

Subclinical airflow obstruction in allergic rhinitis
por: Mishra, Meenakshi, et al.
Publicado: (2014)

Direct and indirect costs of allergic and non‐allergic rhinitis in the Netherlands
por: Avdeeva, Klementina S., et al.
Publicado: (2020)

Sensitization patterns and minimum screening panels for aeroallergens in self-reported allergic rhinitis in China
por: Lou, Hongfei, et al.
Publicado: (2017)

Safety of specific subcutaneous immunotherapy in patients with allergic rhinitis
por: Da Fonseca, Mario Henrique Almeida, et al.
Publicado: (2015)

Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis
por: Sohn, Myung Hyun
Publicado: (2018)

Intradermal Allergen Immunotherapy for Allergic Rhinitis: Current Evidence
por: Atipas, Kawita, et al.
Publicado: (2022)

Brazilian guidelines for allergen immunotherapy in the treatment of allergic rhinitis
por: Aarestrup, Fernando Monteiro, et al.
Publicado: (2023)

Severity of allergic rhinitis and asthma development in children
por: Di Cara, Giuseppe, et al.
Publicado: (2015)

Multiple-Cytokine Profiling: A Novel Method for Early Prediction of the Efficacy of Sublingual Immunotherapy in Allergic Rhinitis Patients
por: Zhang, Yanni, et al.
Publicado: (2022)

Dual systemic allergic rhinitis and local allergic rhinitis
por: Blanca, Miguel, et al.
Publicado: (2015)

EUFOREA Comment on a Misleading Allergic Rhinitis Report [Letter]
por: Scadding, Glenis K, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_97mspnr3kn92noilk5on7ad605